Navigation Links
UC San Diego researcher awarded $3.8 million for new path to breast cancer therapy
Date:9/30/2010

Seth Field, MD, PhD, associate professor in the Department of Medicine at UC San Diego, has been awarded a five-year, $3.86 million "Era of Hope Scholar Award" from the Department of Defense Breast Cancer Research Program. The award supports individuals who have high potential for innovation in breast cancer research early in their careers, researchers considered the "best and brightest" in their field through "extraordinary creativity, vision and productivity and potential for leadership in the breast cancer research community.

Field was one of two scientists selected in the global competition. His project "A New Path to Breast Cancer Therapy" will investigate the mechanism by which a lipid-binding protein called GOLPH3 contributes to cancer.

Recently, Field and colleagues discovered part of the mechanism involving GOLPH3 by which cells export proteins. Interestingly, the gene that encodes GOLPH3 is also a cancer gene that is commonly amplified in human cancers, including approximately one third of breast cancers. Although unprecedented, the identification of GOLPH3 as a cancer gene together with his discovery of its role in a three-way interaction that is required for efficient extracellular transport implicates the process of protein export in the development of cancer.

This award will fund experiments to determine the mechanism by which GOLPH3 causes cancer, the role of protein export in this process, and the suitability of the GOLPH3 pathway as a candidate target for new types of breast cancer therapy.

In 2008, Field was a winner of the NIH New Innovator award to study the function of the group of lipid signaling molecules called phosphoinositides and their target proteins such as GOLPH3. These are molecules which are known to play critical roles in regulating cell growth and death, metabolism, and communication processes within cells.


'/>"/>

Contact: Debra Kain
ddkain@ucsd.edu
619-543-6163
University of California -- San Diego
Source:Eurekalert  

Page: 1

Related medicine news :

1. Type 1 diabetes research at UC San Diego gets $5 million boost
2. UC San Diegos Karin receives prestigious Harvey Prize
3. APA presents latest research on same-sex marriage at annual convention in San Diego
4. UC San Diego researchers find cause of metabolic disease -- and possible cure
5. UC San Diego receives major clinical and translational science award
6. UC San Diego to lead new malaria research center in South America
7. World Renowned Total Artificial Heart Pioneer Dr. Jack Copeland Joins Faculty at UC San Diego
8. Nurtur Unveils the Third Dimension in Healthcare at SHRM 2010 Conference in San Diego
9. NOVAtime participates in the Society for Human Resources Management (SHRM) 62nd Annual Conference in San Diego, California between June 27 and June 29, 2010
10. UC San Diego researcher awarded $5.3 million for breast cancer survivorship study
11. Scripps Memorial Hospital La Jolla First in San Diego to Achieve Magnet Nursing Re-designation
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UC San Diego researcher awarded $3.8 million for new path to breast cancer therapy
(Date:7/10/2014)... HealthDay Reporter THURSDAY, July ... the hot flashes that often accompany menopause, new research suggests. ... percent of menopausal women, said Dr. Taraneh Shirazian, an assistant ... Icahn School of Medicine at Mount Sinai Hospital in New ... 10 hot flashes a day, and she added that hot ...
(Date:7/10/2014)... Dennis Thompson HealthDay Reporter ... of 10 adults make use of calorie information on menus, ... according to a new U.S. study. Women in particular ... Hee Lee-Kwan, an epidemiologist with the U.S. Centers for Disease ... they used menu labeling to help choose their meal, compared ...
(Date:7/10/2014)... experts on aggression, who research issues ranging from child ... World Meeting of the International Society for Research on ... , Georgia State University is hosting the prestigious world ... continents. , "We are excited to be bringing together ... will help produce fresh ideas about the causes, consequences ...
(Date:7/10/2014)... Childhood obesity is one of the top public health ... youths aged 2-19 classified as obese as of 2012. ... and organizations have taken to Twitter to discuss the ... Harris, PhD, assistant professor at the Brown School at ... the hashtag #childhoodobesity in tweets to track Twitter conversations ...
(Date:7/10/2014)... For those students looking to bump up their ... be spending more time in a library or study ... University research shows that students who were members of ... during their freshman and sophomore years had higher GPAs ... indicated that students with memberships stayed in school longer. ...
Breaking Medicine News(10 mins):Health News:Losing Weight May Ease Hot Flashes, Study Finds 2Health News:Losing Weight May Ease Hot Flashes, Study Finds 3Health News:60 Percent of Diners Use Calorie Labeling When Posted: CDC 2Health News:60 Percent of Diners Use Calorie Labeling When Posted: CDC 3Health News:Georgia State hosts national conference on aggression 2Health News:Georgia State hosts national conference on aggression 3Health News:Study looks at how Twitter can be used to address specific health issues 2Health News:Want a higher GPA in college? Join a gym 2
... Barcelona, Spain: An experimental drug that attacks cancer in ... advanced melanoma, delaying progression of the disease and prolonging ... (Wednesday) at the European Cancer Conference (ECCO 14) in ... to chemotherapy more than doubled the amount of time ...
... 26 Biomedtex Inc.,(Pink Sheets: PDNL.PK) ("Biomed" or ... that A. Marc Rocca, 42, will be,President and ... mission is to identify, evaluate and assess a ... and then,seek to capture and promote innovations with ...
... Nycomed Acquires Exclusive Rights Outside North America in Deal Valued ... ... N.J. and ZURICH, Switzerland, Sept. 26, NPS Pharmaceuticals, Inc. (Nasdaq: ... into a definitive agreement,which licenses to Nycomed the rights to ...
... research has yielded a clearer picture of which biomarkers ... colon cancer, bringing closer the day when patients who ... those that will, get the more aggressive treatment they ... doctors plan treatment of colon cancer chiefly by staging ...
... work investigating the reproducibility of glycemic index values, ... Research Center on Aging at Tufts University (USDA ... determinations (measure of the rate of glucose absorption ... white bread, resulted in a relatively high level ...
... to Home and the ... ... pioneer and largest provider of retail-,based health care in the United ... stores in Southeastern,Pennsylvania and Southern New Jersey. MinuteClinic plans to open ...
Cached Medicine News:Health News:New type of drug shows promise in attacking melanoma in an innovative way 2Health News:NPS Pharmaceuticals and Nycomed Announce Licensing Agreement for GATTEX(TM) in Territories Outside North America 2Health News:NPS Pharmaceuticals and Nycomed Announce Licensing Agreement for GATTEX(TM) in Territories Outside North America 3Health News:NPS Pharmaceuticals and Nycomed Announce Licensing Agreement for GATTEX(TM) in Territories Outside North America 4Health News:Study makes progress in zoning in on biomarkers for better colon cancer treatment 2Health News:Glycemic index values are variable, report researchers 2Health News:An Innovation in Health Care Opens at CVS/pharmacy Stores in Philadelphia Metro Area 2Health News:An Innovation in Health Care Opens at CVS/pharmacy Stores in Philadelphia Metro Area 3Health News:An Innovation in Health Care Opens at CVS/pharmacy Stores in Philadelphia Metro Area 4Health News:An Innovation in Health Care Opens at CVS/pharmacy Stores in Philadelphia Metro Area 5
(Date:7/10/2014)... 2014 Yesterday, former Congressman Patrick ... manufacturing facility. Rep. Kennedy and Dick Moberg ... cutting-edge research in neurological disease and treatment. ... advocate, Garen Staglin , created One Mind, ... changes that will radically accelerate the development and ...
(Date:7/10/2014)... , July 10, 2014   Ventana Medical ... today announced it has entered into an agreement with ... operates as EMD Serono in the United ... to collaborate with Merck KGaA,s biopharmaceutical division on the ... an undisclosed target using Ventana,s proprietary diagnostic assays. In ...
(Date:7/10/2014)... CVS Caremark Corporation (NYSE: CVS ) ... quarterly dividend of $0.275 (27.5 cents) per share on the ... 2014, to holders of record on July 21, 2014. ... dedicated to helping people on their path to better health ... United States . Through the company,s more than 7,600 ...
Breaking Medicine Technology:Representative Patrick Kennedy visits Moberg's medical device facility to discuss improvement in brain injury care 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3
... gout flares can be treated safely with Colcrys® (colchicine, ... often present physicians with treatment challenges, according to a ... Meeting of the American College of Rheumatology (ACR). ... conditions to consider, including cardiovascular and metabolic disorders, hypertension ...
... 8, 2010 Substandard and counterfeit versions of thirteen ... Ghana by the Medicines Quality Monitoring surveillance program. Set ... in collaboration with the U.S. Pharmacopeial Convention (USP) and ... samples antimalarials across the public and private sectors. It ...
Cached Medicine Technology:Data Presented at ACR Meeting Demonstrate Safety of Colcrys® (Colchicine, USP) for Treatment of Gout Flares in Patients with Multiple Co-Morbid Conditions 2Data Presented at ACR Meeting Demonstrate Safety of Colcrys® (Colchicine, USP) for Treatment of Gout Flares in Patients with Multiple Co-Morbid Conditions 3Data Presented at ACR Meeting Demonstrate Safety of Colcrys® (Colchicine, USP) for Treatment of Gout Flares in Patients with Multiple Co-Morbid Conditions 4Substandard and Counterfeit Antimalarial Drugs in Ghana Discovered by Cooperative Program of USP, Ghana Food and Drugs Board 2Substandard and Counterfeit Antimalarial Drugs in Ghana Discovered by Cooperative Program of USP, Ghana Food and Drugs Board 3
The S7 Elite is the premium device in ResMeds award-winning S7 series. All S7 devices include an option of integrated humidification....
... Enjoy freedom and flexibility with ... optional rechargeable battery pack, the system ... household current. Also includes an integrated ... provides enough water for one nights ...
The clarity and performance of glass with shatterproof safety of plastic....
Hemato-clad Hematocrit Tubes combine the precision of glass with the safety provided by a Mylar® overwrap. Now you can give your laboratory staff safety with no compromise in accuracy....
Medicine Products: